Tetsuro Kikuchi

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 922 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

Shaun Jordan, Vuk Koprivica, Ruoyan Chen et al. · European Journal of Pharmacology · 2002 · 509 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 362 citations

Medicine, Pharmacology, Psychiatry +15

Analysis of the p53 gene and its expression in human glioblastoma cells.

Erwin G. Van Meir, Tetsuro Kikuchi, Mitsuhiro Tada et al. · PubMed · 1994 · 331 citations

Medicine, Genetics, Oncology +13

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

Tetsuro Kikuchi, Katsura Tottori, Yasufumi Uwahodo et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 275 citations · Full text

Medicine, Neuroscience, Pharmacology +17